CEV: Saba Capital files 13D/A showing major 8 % ownership
Rhea-AI Filing Summary
Amendment No. 7 to Schedule 13D filed on 06/30/2025 reveals that Saba Capital Management, L.P., its general partner Saba Capital Management GP, LLC, and portfolio manager Boaz R. Weinstein (together, the “Reporting Persons”) now beneficially own 565,481 common shares of Eaton Vance California Municipal Income Trust (ticker CEV), representing 8.04 % of the fund’s outstanding shares (7,033,575 as of 12/30/24).
• Voting/Dispositive power: All shares are held with shared voting and shared dispositive power; none are held solely.
• Cost basis: Approximately $6.11 million was paid to acquire the position, funded through investor subscriptions, capital appreciation and ordinary-course margin borrowings.
• Amended items: The filing updates Items 3 (Source of Funds), 5 (Interest in Securities) and 7 (Exhibits).
The Reporting Persons have not stated a specific purpose for the investment (Item 4 marked “Not Applicable”) and report no related contracts, arrangements or legal proceedings. Transactions executed within the 60-day window preceding 06/27/2025 are detailed in Schedule A (not included in the excerpt).
This 13D (rather than a passive 13G) formally discloses an ownership level above the 5 % threshold, giving Saba Capital the status of an “insider” under Section 13 of the Exchange Act and providing it the ability to influence corporate actions subject to future disclosures.
Positive
- Institutional accumulation: Saba Capital’s 8.04 % stake signals meaningful outside interest in CEV.
- Capital commitment: Roughly $6.1 million invested, providing liquidity and potential support for the share price.
Negative
- Unclear intentions: Item 4 lists no purpose, leaving investors without guidance on Saba’s strategic objectives.
Insights
TL;DR: Saba Capital now holds 8.0 % of CEV; $6.1 m invested, no stated agenda, but 13D filing may indicate potential activism.
Impact assessment: The disclosure is potentially impactful because ownership above 5 %—especially via a 13D—gives the holder leverage to influence distribution policy, leverage levels or possible tender offers that could narrow the fund’s discount to NAV. The stake cost of roughly $6.1 m suggests an average price near $10.80 per share, implying Saba accumulated shares in size without sole control. However, the absence of an articulated purpose tempers immediate conclusions. Investors should monitor subsequent filings or public statements for indication of strategy, as further action (e.g., proxy proposals) would materially affect valuation.